ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628115 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628115; 2) Community: the network communities that were significantly associated with the response to NSC 628115; 3) Molecule: the relationships between components within communities and NSC 628115; 4) MDR: the compounds that were significantly associated with the NSC 628115.

NSC Compound Enrichment Correlation
NSC 737147 2-(4-Chloroanilino)-N'-[(4-acetylaminophenyl)sulphonyl]nicotino hydrazide 0.0102077332082017 0.13522329
NSC 748541 1-Methylene-2-(4-methoxybenzyl)-3-(3-chlorophenyl)-1,2-dihydropyrazino[1,2-a]-benzimidazole 0.0102077332082017 0.25708244
NSC 748870 Null 0.0102077332082017 0.32386092
NSC 763232 Null 0.0102077332082017 0.19332902
NSC 83066 8-Quinolinol, 5-(chloromethyl)-, hydrochloride 0.0102077332082017 0.34823535
NSC 87500 Solacongestidine 0.0102077332082017 0.26444863
NSC 630307 Null 0.0102962192514438 0.26091308
NSC 635000 Null 0.0102962192514438 0.36162332
NSC 639503 Cyclopentanone, 2-hexylidene-5-[(4-morpholinyl)methyl]-, hydrochloride 0.0102962192514438 0.49133112
NSC 653624 Null 0.0102962192514438 0.37194504
Total:180  Current:71    [First] [Prev] [Next] [Last]